Onabotulinumtoxina

Common brands: Botox Cosmetic, Botox, Neurontin, Topamax, Vitamin D

Top reporter: Allergan, Inc.

Acetylcholine Release Inhibitor [EPC]Neuromuscular Blocker [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Benzodiazepine [EPC]Provitamin D2 Compound [EPC]
75,403
Total Reports
25,888
Serious Reports
2,014
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (2.67%)

Patient Demographics

Male
7,847
Female
54,553

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Onabotulinumtoxina.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 26,395
29.1%
2 OFF LABEL USE 11,313
12.5%
3 THERAPEUTIC RESPONSE DECREASED 4,505
5.0%
4 HEADACHE 4,008
4.4%
5 PRODUCT PREPARATION ERROR 3,655
4.0%
6 INJECTION SITE PAIN 3,388
3.7%
7 EYELID PTOSIS 3,111
3.4%
8 MULTIPLE USE OF SINGLE-USE PRODUCT 2,819
3.1%
9 MIGRAINE 2,285
2.5%
10 NAUSEA 2,111
2.3%
11 PAIN 1,863
2.1%
12 FATIGUE 1,803
2.0%
13 MUSCULAR WEAKNESS 1,781
2.0%
14 DIZZINESS 1,757
1.9%
15 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1,716
1.9%
16 DYSPHAGIA 1,693
1.9%
17 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1,588
1.7%
18 DYSPNOEA 1,517
1.7%
19 DEATH 1,474
1.6%
20 VISION BLURRED 1,336
1.5%
21 ASTHENIA 1,242
1.4%
22 NECK PAIN 1,117
1.2%
23 INJECTION SITE SWELLING 1,091
1.2%
24 SWELLING FACE 1,090
1.2%
25 RASH 1,083
1.2%
26 THERAPEUTIC RESPONSE SHORTENED 1,072
1.2%
27 HYPOAESTHESIA 1,052
1.2%
28 ANXIETY 1,009
1.1%
29 MALAISE 945
1.0%
30 FACIAL PARESIS 936
1.0%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.